MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
IMNM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Immunome (IMNM) Ownership - Who owns Immunome?

Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
18702 N. Creek Parkway
Phone
+1 425 939-7410
Employees
177
Web
https://www.immunome.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.17B
P/E Ratio
N/A
Total Cash
582.69M
Projected Growth
N/A
Total Debt
3.69M
Revenue
4.02M
Risk (Beta)
1.81
Dividend Yield
N/A
Total Cash/Share
5.15
Total Debt/Equity
N/A
Revenue/Share
0.04 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
IMNM
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for IMNM
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
18702 N. Creek Parkway
Phone
+1 425 939-7410
Employees
177
Web
https://www.immunome.com